Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Drug Development

Rare Diseases Eli Lilly Phase 3 Trials Treatment Oveporexton Aleniglipron Weight Loss Limb-Girdle Muscular Dystrophy Obesity Treatments Inflammatory Diseases

Law Firms Press Soleno Investors to Seek Lead Role in Securities Suit by May 5

Plaintiffs say Soleno hid safety risks tied to its only drug.

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

Structure’s Oral Obesity Pill Delivers 16.3% Placebo-Adjusted Weight Loss in Phase 2

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

Oral PCSK9 Pill Enlicitide Cuts LDL Up to 60% in Phase 3 Trial

Viking Therapeutics Jumps After Wider Q3 Loss as R&D Ramp Signals Obesity-Drug Progress

Orexin-2 Agonists Lift Wakefulness in Narcolepsy as Takeda Leads With Late-Stage Wins

SPARC Shares Plunge Nearly 20% After Failed Phase 2 Vibozilimod Trials

New Non-Hormonal Drug Shows Promise for Menopausal Hot Flashes

Alnylam's Heart Drug Shows Promising Phase-3 Results, Boosting Stock